Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-05-17 @ 10:00 PM
Study NCT ID:
NCT01100320
Status:
COMPLETED
Last Update Posted:
2010-05-11
First Post:
2010-04-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
Sponsor:
Purdue Pharma LP
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OTR1004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Medical Monitor
Old Organization:
Purdue Pharma L.P.